|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1999-5-5
|
|
pubmed:abstractText |
Infusion of large amounts of intravenous immunoglobulin (IVIG) or anti-D can reverse the low platelet count in patients with ITP within hours of the initiation of treatment. In some cases, the effects of IVIG appear to far outlast several half-lives of the product. Several mechanisms have been proposed to explain these rapid and long term effects and these will be discussed in this review.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
T
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0955-3886
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
289-94
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10351141-Antibodies, Anti-Idiotypic,
pubmed-meshheading:10351141-Autoantibodies,
pubmed-meshheading:10351141-Autoimmune Diseases,
pubmed-meshheading:10351141-Blood Platelets,
pubmed-meshheading:10351141-Clinical Trials as Topic,
pubmed-meshheading:10351141-Half-Life,
pubmed-meshheading:10351141-Humans,
pubmed-meshheading:10351141-Immunoglobulin G,
pubmed-meshheading:10351141-Immunoglobulin M,
pubmed-meshheading:10351141-Immunoglobulins, Intravenous,
pubmed-meshheading:10351141-Isoantibodies,
pubmed-meshheading:10351141-Macrophage Activation,
pubmed-meshheading:10351141-Mononuclear Phagocyte System,
pubmed-meshheading:10351141-Purpura, Thrombocytopenic, Idiopathic
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
|
|
pubmed:affiliation |
Canadian Blood Services, Toronto Centre, ON, Canada.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|
